skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8102

Therapeutics and Clinical Risk Management

(2,215,719) Views

Editor in Chief Professor Garry Walsh

1178-203X


Nonsteroidal antiinflammatory drugs (NSAIDs) and physiotherapy management of musculoskeletal conditions: a professional minefield?
Saravana Kumar, Karen Grimmer
Therapeutics and Clinical Risk Management 2005, 1:69-76
12 May 2005


Differential associations between actual and expected GP practice prescribing rates for statins, ACE inhibitors, and beta-blockers: a cross-sectional study in England
Paul R Ward, Peter R Noyce, Antony S St Leger
Therapeutics and Clinical Risk Management 2005, 1:61-68
20 January 2005


Depression and drug utilization in an elderly population
Raffaele Antonelli Incalz, Andrea Corsonello, Claudio Pedone, Francesco Corica, Pierugo Carbonin
Therapeutics and Clinical Risk Management 2005, 1:55-60
20 January 2005


Use of intravenous antibiotics for the treatment of community-acquired pneumonia in the emergency department
Anita G Carrie, Thomas J Marrie,
Therapeutics and Clinical Risk Management 2005, 1:49-54
20 January 2005


Drug-related problems in hospitalized patients on polypharmacy: the influence of age and gender
Yvonne Koh, Fatimah Bte Moideen Kutty, Shu Chuen Li
Therapeutics and Clinical Risk Management 2005, 1:39-48
20 January 2005


Patient medication knowledge and adherence to asthma pharmacotherapy: a pilot study in rural Australia
Tabitha J Franks, Deborah L Burton, Maree D Simpson
Therapeutics and Clinical Risk Management 2005, 1:33-38
20 January 2005


Elective open abdominal aortic aneurysm repair: a seven-year experience
Stuart MacKenzie, judith R Swan, Cate D’Este,  Allan D Spigelman
Therapeutics and Clinical Risk Management 2005, 1:27-31
20 January 2005


Should valproate be taken during pregnancy?
Mervyn J Eadie, Frank JE Vajda
Therapeutics and Clinical Risk Management 2005, 1:21-26
20 January 2005


Principles in genetic risk assessment || FREE PAPER ||
Pedro Viana Baptista
Therapeutics and Clinical Risk Management 2005, 1:15-20
20 January 2005


Clinical outcomes and management of mechanism-based inhibition of cytochrome P450 3A4
Shufeng Zhou, Eli Chan, Xiaotian Li, Min Huang
Therapeutics and Clinical Risk Management 2005, 1:3-13
20 January 2005


Editorial || FREE PAPER ||
Garry Walsh
Therapeutics and Clinical Risk Management 2005, 1:1-1
12 May 2005